Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study

BACKGROUND: Patients with intermediate to advanced hepatocellular carcinoma (HCC) are most commonly treated with transarterial chemoembolization (TACE). Previous studies showed that TACE combined with recombinant human adenovirus type 5 (H101) may provide a clinical survival benefit. In the present...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chin J Cancer
Hlavní autoři: He, Chao-Bin, Lao, Xiang-Ming, Lin, Xiao-Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518415/
https://ncbi.nlm.nih.gov/pubmed/28728568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-017-0227-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky